Skip to main content

Table 2 Comparison of HDL components in non-diabetic subjects and T2DM patients

From: Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients

Characteristics All Female Male
Non-diabetic T2DM Non-diabetic T2DM Non-diabetic T2DM
N in category 298 300 149 150 149 150
Cholesterol (mg/dL) 53.8 (13.3) 46.8 (12.3)§ 54.6 (12.8) 49.8 (9.7)ǂ 52.9 (13.88) 43.8 (13.9)§
ApoA-I (μg/mL) 7.8 (2.2) 6.8 (2.6)§ 7.5 (2.0) 6.9 (2.6)ł 8.0 (2.4) 6.9 (2.6)ǂ
Serum amyloid A (μg/L) 811.9 (286.8) 928.5 (326.8)§ 924.8 (265.3) 1021.9 (335.2)* 691.6 (244.4) 836.0 (291.0)§
Phospholipid (pg/mL) 963.8 (438.4) 1080.5 (391.1)ǂ 992.4 (413.8) 1045.9 (349.6) 933.6 (462.3) 1115.1 (427.0)ǂ
sphingosine-1-phosphate (nmol/L) 1549.7 (473.3) 1464.3 (699.9) 1465.0 (450.5) 1429.4 (769.2) 1629.3 (480.2) 1499.3 (623.6)*
Triglycerides (log, mg/dl) 13.6 (10.8–16.4) 13.0 (10.6–17.6) 12.3 (9.7–16.0) 15.0 (11.4–19.4)ǂ 14.0 (11.7–16.8) 11.8 (9.4–15.0)
  1. § p < 0.0001;ǂ p < 0.001; ł p < 0.01; * p < 0.05 when compared with non-diabetic controls